Immusoft

Immusoft

Immusoft

Immusofts mission is to develop a completely new platform for delivering medicines programming a patients own cells to become miniature drug factories.
Type
B2c
Founded
2009
Raised
$30.2M
Follow us
Alexa global traffic share
Twitter followers
04 Jan 2019
$20,000,000
Venture capital (Series B)

Immusoft Raises $20M in Series B Financing

FinSMEs
+3
05 Jan 2018
07 Nov 2016
$2,700,000
Venture capital (Series A)
FF Science, Technium Partners

http://immusoft.com/wp-content/uploads/2016/11/Immusoft-Closes-Round-Nov-2016.pdf

Immusoft Corporation
+1